Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,612 | 20,890 | 33,662 | 41,649 | 47,078 |
| Receivables | 12,497 | 12,535 | 10,545 | 13,477 | 11,858 |
| Inventories | 10,630 | 11,146 | 11,059 | 8,690 | 2,055 |
| Other current assets | 0 | 104 | 282 | 660 | 271 |
| TOTAL | $45,911 | $46,930 | $58,090 | $66,524 | $63,100 |
| Non-Current Assets | |||||
| PPE Net | 1,384 | 1,328 | 1,249 | 1,154 | 1,276 |
| Intangibles | 253,404 | 254,705 | 229,465 | 235,669 | 252,050 |
| Other Non-Current Assets | 3,207 | 3,029 | 3,029 | 3,061 | 3,245 |
| TOTAL | $257,995 | $259,062 | $233,743 | $239,884 | $256,571 |
| Total Assets | $303,906 | $305,992 | $291,833 | $306,408 | $319,671 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,750 | 9,000 | 6,875 | 6,250 | 5,625 |
| Accounts payable and accrued liabilities | 14,223 | 14,565 | 15,315 | 22,087 | 13,466 |
| Other current liabilities | 6,216 | 6,372 | 10,049 | 14,388 | 21,812 |
| TOTAL | $35,642 | $35,428 | $37,936 | $48,908 | $47,139 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,205 | 99,027 | 82,765 | 84,696 | 86,582 |
| Other Non-Current Liabilities | 2,034 | 1,987 | 2,001 | 1,971 | 4,755 |
| TOTAL | $99,015 | $101,721 | $85,321 | $88,008 | $94,333 |
| Total Liabilities | $134,657 | $137,149 | $123,257 | $136,916 | $141,472 |
| Shareholders' Equity | |||||
| Common Shares | 257,411 | 256,292 | 256,283 | 256,250 | 248,687 |
| Retained earnings | -101,575 | -93,056 | -90,122 | -82,478 | -81,468 |
| Other shareholders' equity | 2,020 | -5,365 | -8,275 | -14,581 | -537 |
| TOTAL | $169,249 | $168,843 | $168,576 | $169,492 | $178,199 |
| Total Liabilities And Equity | $303,906 | $305,992 | $291,833 | $306,408 | $319,671 |